Rebecca Thomason

Rebecca Thomason, MBA, serves as a Senior Clinical Project Manager at Translational Drug Development (TD2) since February 2022, previously holding the role of Project Manager. Prior experience includes serving as Clinical Research Program Manager at Vyriad, where operations management focused on multi-center clinical programs targeting oncolytic viruses for Phase I and II trials. With a strong background in project management, Rebecca has overseen all aspects of clinical trial execution, including writing standard operating procedures and managing project timelines, budgets, and regulatory documents. Earlier roles at Mayo Clinic involved independent management of Phase I clinical trials within the Early Cancer Therapeutics Program and administrative support within the Department of Surgery. Educational achievements include an MBA in Health Care Administration from Western Governors University, an MA in Counseling Psychology, and a BS in Psychology from Saint Mary's University of Minnesota.